Interní Med. 2002; 4(3): 9-11

Cílové hodnoty při léčbě hypertenze

doc. MUDr. Vladimír Tesař DrSc
I. interní klinika 1. LF UK a VFN Praha

Published: December 31, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tesař V. Cílové hodnoty při léčbě hypertenze. Interní Med. 2002;4(3):9-11.

Krevní tlak vyšší než 130/85 (a nepochybně krevní tlak vyšší než 140/90) zvyšuje kardiovaskulární riziko. Z normalizace krevního tlaku profitují zejména nemocní s vysokým absolutním rizikem kardiovaskulárních komplikací, např. starší nemocní, včetně nemocných s izolovanou systolickou hypertenzí. Cílovou hodnotou krevního tlaku pro všechny hypertoniky je krevní tlak nižší než 140/90. U diabetiků lze vysoké kardiovaskulární riziko dále snížit redukcí krevního tlaku pod 130/85. U proteinurických pacientů s chronickou renální insuficiencí je cílový krevní tlak (snižující nejvýrazněji progresi chronické renální insuficience) nižší než 125/75.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Colhoun HM, Dong W, Poulter NR. Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens 1998; 16: 747-752. Go to original source... Go to PubMed...
    2. Dahlof B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-1285. Go to original source... Go to PubMed...
    3. Guidelines Committee: 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. J Hypertens 1999; 17: 151-183. Go to original source...
    4. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-1762. Go to original source... Go to PubMed...
    5. Horký K, Widimský J, Cífková R, Widimský JJr. Doporučení diagnostických a léčebných postupů u arteriální hypertenze - návrh verze 2000. Hypertenze 2000; 3: 3-13.
    6. Hypertension Detection and Follow-up Program Cooperative Group: Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction of mortality of persons with high blood pressure, including mild hypertension. JAMA 1979; 242: 2562-2571. Go to original source...
    7. Kannel WB, Dawber T. Perspectives on systolic hypertension: The Framingham Study. Circulation 1980; 61: 1179-1182. Go to original source... Go to PubMed...
    8. Lazarus JM, Bourgoignie JJ, Buckalew VM, et al. Achievement and safety of a low blood pressure goal in chronic renal disease. Hypertension 1997; 29: 641-650. Go to original source... Go to PubMed...
    9. Lewis EJ, Hunsicker LG, Bain RP, et al. The effect of angiotensin-convertingenzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462. Go to original source... Go to PubMed...
    10. Staessen JA, Fagard R, Thijs L, et al. Morbidity and mortality in the placebocontrolled European Trial on Isolated Systolic Hypertension in the Elderly. Lancet 1997; 360: 757-764. Go to original source... Go to PubMed...
    11. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic and cardiovascular risks: US population data. Arch Intern Med 1993; 153: 598-615. Go to original source...
    12. Systolic Hypertension in the Elderly Program Cooperative Research Group: Implications of the Systolic Hypertension in the Elderly Program. Hypertension, 1993; 21: 335-343. Go to original source...
    13. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-1297. Go to original source... Go to PubMed...
    14. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averagingn 115 through 129 mm Hg. JAMA 1967; 202: 1028-1034. Go to original source... Go to PubMed...
    15. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Brit Med J 1998; 317: 703-713. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.